Uptake and barriers to cervical cancer screening among human immunodeficiency virus-positive women in Sub Saharan Africa: a systematic review and meta-analysis

[1] Shibuya K(2002)Global and regional estimates of cancer mortality and incidence by site: II The results for the global burden of disease 2000 BMC Cancer 2 37-527

[2] Mathers CD(2015)The global burden of cancer 2013 JAMA Oncol 1 505-250

[3] Boschi-Pinto C(2012)A million Africans a year dying from cancer by 2030: what can cancer research and control offer to the continent? Int J Cancer 130 245-1010

[4] Lopez AD(2015)Global surveillance of cancer survival 1995–2009: analysis of individual data for 25,676,887 patients from 279 population-based registries in 67 countries (CONCORD-2) Lancet 385 977-134

[5] Murray CJ(2015)Cervical cancer screening in sub-S aharan A frica: A randomized trial of VIA versus cytology for triage of HPV-positive women Int J Cancer 137 127-2265

[6] Fitzmaurice C(2011)HIV and cancer in Africa: mutual collaboration between HIV and cancer programs may provide timely research and public health data Infectious agents and cancer 6 16-23

[7] Dicker D(2008)The spectrum of human immunodeficiency virus-associated cancers in a South African black population: Results from a case–control study, 1995–2004 Int J Cancer 122 2260-258

[8] Pain A(2016)Higher prevalence of human papillomavirus-related cervical precancerous abnormalities in HIV-infected compared to HIV-uninfected women J Natl Med Assoc 108 19-49

[9] Hamavid H(2014)The burden, distribution and risk factors for cervical oncogenic human papilloma virus infection in HIV positive Nigerian women Virology J 11 5-276

[10] Moradi-Lakeh M(2010)Practice improvement in cervical screening and management (PICSM): symposium on management of cervical abnormalities in adolescents and young women J Low Genit Tract Dis 14 73-722

[1] Shibuya K(2002)Global and regional estimates of cancer mortality and incidence by site: II The results for the global burden of disease 2000 BMC Cancer 2 37-527

[2] Mathers CD(2015)The global burden of cancer 2013 JAMA Oncol 1 505-250

[3] Boschi-Pinto C(2012)A million Africans a year dying from cancer by 2030: what can cancer research and control offer to the continent? Int J Cancer 130 245-1010

[4] Lopez AD(2015)Global surveillance of cancer survival 1995–2009: analysis of individual data for 25,676,887 patients from 279 population-based registries in 67 countries (CONCORD-2) Lancet 385 977-134

[5] Murray CJ(2015)Cervical cancer screening in sub-S aharan A frica: A randomized trial of VIA versus cytology for triage of HPV-positive women Int J Cancer 137 127-2265

[6] Fitzmaurice C(2011)HIV and cancer in Africa: mutual collaboration between HIV and cancer programs may provide timely research and public health data Infectious agents and cancer 6 16-23

[7] Dicker D(2008)The spectrum of human immunodeficiency virus-associated cancers in a South African black population: Results from a case–control study, 1995–2004 Int J Cancer 122 2260-258

[8] Pain A(2016)Higher prevalence of human papillomavirus-related cervical precancerous abnormalities in HIV-infected compared to HIV-uninfected women J Natl Med Assoc 108 19-49

[9] Hamavid H(2014)The burden, distribution and risk factors for cervical oncogenic human papilloma virus infection in HIV positive Nigerian women Virology J 11 5-276

[10] Moradi-Lakeh M(2010)Practice improvement in cervical screening and management (PICSM): symposium on management of cervical abnormalities in adolescents and young women J Low Genit Tract Dis 14 73-722